An outcomes-based approach to decisions about drug coverage policies in British Columbia

Psychiatric Services

Volumn 55, Issue 11, 2004, Pages 1230-1232

  Morgan, Steve ^a   Bassett, Ken ^a   Mintzes, Barbara ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANADA; CONSUMER; CONTINUING EDUCATION; COST BENEFIT ANALYSIS; EVIDENCE BASED MEDICINE; MEDICAL DECISION MAKING; MEDICAL PRACTICE; OUTCOMES RESEARCH; POLICY; PRESCRIPTION; SHORT SURVEY;

BRITISH COLUMBIA; COST SAVINGS; DRUG COSTS; EVIDENCE-BASED MEDICINE; HEALTH POLICY; HUMANS; INSURANCE COVERAGE; INSURANCE, PHARMACEUTICAL SERVICES; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHOTROPIC DRUGS; RANDOMIZED CONTROLLED TRIALS; RESOURCE ALLOCATION;

EID: 7444241365     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.55.11.1230     Document Type: Short Survey

References (2)

1. Courtney C, Farrell D, Gray R, et al: Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet 363: 2105-2115, 2004
2. Morgan S, Bassett K, Mintzes B: Outcomes-based drug coverage in British Columbia. Health Affairs 23(3):269-276, 2004